Unexplained Stillbirths: Understanding The Complexities
Keywords:
Unexplained stillbirth, fetal growth restriction (FGR), Genetic mutations, Chromosomal microarray, maternal healthAbstract
Background: Stillbirth, intrauterine fetal death after 20 weeks of gestation, is a sad and under-recognised complication in obstetrics. Despite technological advancements, a significant proportion of stillbirths are "unexplained," which makes preventive measures impossible.
Objective: It presents a comprehensive overview of different causes of unexplained stillbirths and gives thought to prevailing gaps and possibilities of future investigation.
Methods: Systematic literature review on PubMed, Scopus, and Google Scholar on published literature for the year 2010 through 2025. The key words were "unexplained stillbirth," "placental pathology," "genetic causes," and "immunologic factors." Peer-reviewed human research published in English language was used as the inclusion criteria. The exclusion criteria used were animal model studies, case reports, and non-peer-reviewed literature.
Results: The major findings emphasized the importance of established maternal, fetal, placental, genetic, and environmental determinants. Of the major challenges enumerated were the diagnostic limitations, heterogenous classification schemes, and the inappropriate use of advanced genetic techniques.
Conclusion: Multidisciplinary coordination, expanded utilization of molecular diagnostics, and standardization of postmortem protocols will be necessary to minimize unexplained rates and optimize maternal-fetal outcomes for unexplained stillbirth.
Downloads
References
World Health Organization. Making Every Baby Count: Audit and Review of Stillbirths and Neonatal Deaths. Geneva: WHO; 2016.
Lawn JE, Blencowe H, Waiswa P, et al. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016; 387(10018):587–603.
Hug L, You D, Blencowe H, et al. Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment. Lancet. 2021; 398(10302):772–85.
UNICEF India. India ranks highest in the number of stillbirths worldwide. 2020 [Internet]. Available from: https://www.unicef.org/india
Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011; 377(9774):1331–40.
Heazell AE, Siassakos D, Blencowe H, et al. Stillbirths: economic and psychosocial consequences. Lancet. 2016; 387(10018):604–16.
Cacciatore J, Erlandsson K, Rådestad I. Fatherhood and suffering: A qualitative exploration of Swedish men's experiences of care after the death of a baby. Int J Nurs Stud. 2013; 50(5):664–70.
World Health Organization. Stillbirth. 2020 [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/stillbirth
MacDorman MF, Gregory ECW. Fetal and Perinatal Mortality: United States, 2013. Natl Vital Stat Rep. 2015; 64(8):1–24.
Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population-based cohort study. BMJ. 2005; 331(7525):1113–7.
Flenady V, Wojcieszek AM, Middleton P, et al. Stillbirths: recall to action in high-income countries. Lancet. 2016; 387(10019):691–702.
Gordijn SJ, Erwich JJ, Khong TY. Value of the perinatal autopsy: critique. Pediatr Dev Pathol. 2002; 5(5):480–8.
Breeze AC, Lees CC, Kumar A, et al. Perinatal postmortems: what is important to parents and how do they decide? BJOG. 2011; 118(8):928–35.
Reddy UM, Page GP, Saade GR. The role of genetic analysis in the evaluation of stillbirth. Obstet Gynecol. 2015; 126(4):934–44.
Petrikin JE, Cakici JA, Clark MM, et al. The NSIGHT1-randomized trial: rapid whole-genome sequencing for suspected genetic conditions in neonatal intensive care. Am J Hum Genet. 2018; 103(4):570–84.
Silver RM, Varner MW, Reddy UM, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol. 2007; 196(5):433–44.
Iqbal S, Raza S, Siddiqui N. The Etiology of Stillbirths Using Relevant Condition at Death (ReCoDe) Classification System: A Prospective Cross-sectional Study. J SocObstetGynaecol Pak. 2024; 14(2):45–50.
PSANZ Stillbirth and Neonatal Death Alliance. PSANZ Perinatal Mortality Classification Version 3.2. Perinatal Society of Australia and New Zealand; 2020.
Frøen JF, Cacciatore J, McClure EM, et al. Stillbirths: why they matter. Lancet. 2011; 377(9774):1353–66.
Saidi N, Trabelsi A, Mansouri I, et al. Value of CODAC classification in identifying causes of stillbirths in Tunisia. Arch Gynecol Obstet. 2025; 311(3):567–74.
Uyanik G, Baquero J, Madan-Khetarpal S. Stillbirth and genetic testing: a practical review. Am J Med Genet C Semin Med Genet. 2020; 184(1):91–102.
Gold KJ, Abdul-Mumin AR, Boggs ME, et al. Assessment of global stillbirth classification systems: a systematic review. BMC Pregnancy Childbirth. 2025; 25(1):345.
Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016; 140(7):698–713.
Gardosi J, Madurasinghe V, Williams M, et al. Maternal and fetal risk factors for stillbirth: population-based study. BMJ. 2013; 346:f108.
McClure EM, Goldenberg RL. Infection and stillbirth. Semin Fetal Neonatal Med. 2009; 14(4):182–9.
Redline RW. Classification of placental lesions. Am J Obstet Gynecol. 2015; 213(4 Suppl):S21–8.
Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol. 2003; 189(3):861–73.
Willinger M, Kooper AJ, Butwicka A, et al. Whole-exome sequencing in the evaluation of stillbirth: diagnostic yield and clinical implications. Genet Med. 2023; 25(2):100–10.
Stacey T, Thompson JM, Mitchell EA, et al. Maternal sleep practices and stillbirth risk: a prospective case-control study. BMJ. 2024; 384:g847.
Heazell AEP, Warland J, Stacey T, et al. Stillbirths: risk factors and prevention strategies. BJOG. 2024; 131(4):372–82.
Breeze AC, Jessop FA, Set PA, et al. Minimally invasive fetal autopsy using MRI and biopsies: clinical value and comparison. Ultrasound Obstet Gynecol. 2011; 37(3):317–23.
Heazell AEP, McLaughlin MJ, Schmidt EB, et al. A difficult conversation? Talking to bereaved parents about autopsy. BJOG. 2012; 119(8):987–97.
Menendez C, Castillo P, Martinez MJ, et al. Validity of minimally invasive autopsy in stillbirths in Mozambique. PLoS Med. 2017; 14(6):e1002318.
McClure EM, Saleem S, Pasha O, Goldenberg RL. Stillbirth in developing countries: a review. J Matern Fetal Neonatal Med. 2009; 22(3):183–90.
Cacciatore J. Psychological effects of stillbirth on families. Grief Matters. 2010; 13(1):4–9.
McPherson E. Genetic diagnosis and perinatal loss. Semin Fetal Neonatal Med. 2010; 15(1):17–20.
Wou K, Levy B. Genetic evaluation of stillbirth. ClinPerinatol. 2018;45(2):305–16.
Horne RG, Highet AR, Gordon A, Scarf VL, Jeffery HE. Maternal obesity and the risk of stillbirth: a population-based cohort study. BJOG. 2021; 128(9):1469–76.
Martines RB, Bhatnagar J, Keating MK, et al. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016; 65(6):159–60.
Warland J, O’Brien LM, Heazell AEP, et al. Stillbirth: informing practice and improving bereavement care. Br J Midwifery. 2011; 19(10):644–9.
Cacciatore J, DeFrain J, Jones KL, Jones H. Stillbirth and the couple: a gender-based exploration. J FamSoc Work. 2008; 11(4):351–72.
Vaiman D. Genetic regulation of placental development and stillbirth. Best Pract Res ClinObstetGynaecol. 2010; 24(5):665–76.
Man J, Hutchinson C, Heazell AEP. Placental pathology findings in unexplained pregnancy losses. J Matern Fetal Neonatal Med. 2023; 36(3):1–9.
Kliman HJ. The placenta holds answers to many unexplained pregnancy losses. Yale School of Medicine News. 2023.
Man J, Hutchinson C, Heazell AEP. Placental pathology findings in unexplained pregnancy losses. J Matern Fetal Neonatal Med. 2023; 36(3):1–9.
Roberts DJ. Autopsies can help explain stillbirths. Too few are performed. ProPublica. 2022.
Society for Maternal-Fetal Medicine. SMFM Consult Series #52: Diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2020; 223(5):B2–B17.
Society for Maternal-Fetal Medicine. SMFM Consult Series #52: Diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2020; 223(5):B2–B17.
Lee HC, et al. The contribution of an infectious workup to understanding stillbirth. Am J Obstet Gynecol. 2018; 218(1):S239.
Lee HC, et al. The contribution of an infectious workup to understanding stillbirth. Am J Obstet Gynecol. 2018; 218(1):S239.
Stanley KE, et al. Genomics of stillbirth: an analysis of 246 cases. PrenatDiagn. 2020; 40(9):1111–1120.
Stanley KE, et al. Genomics of stillbirth: an analysis of 246 cases. PrenatDiagn. 2020; 40(9):1111–1120.
Rodriguez A, et al. Association of maternal hypertension with stillbirth: a population-based study. Hypertens Pregnancy. 2021; 40(1):1–7.
Jansen P, et al. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2023; 21(1):1–15.
Lee ACC, Kozuki N, Cousens S, et al. Intrapartum-related neonatal encephalopathy and impairment: global burden. Pediatr Res. 2013; 74(Suppl 1):50–72.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.